3ik3
From Proteopedia
(Difference between revisions)
Line 12: | Line 12: | ||
===AP24534, a Pan-BCR-ABL Inhibitor for Chronic Myeloid Leukemia, Potently Inhibits the T315I Mutant and Overcomes Mutation-Based Resistance=== | ===AP24534, a Pan-BCR-ABL Inhibitor for Chronic Myeloid Leukemia, Potently Inhibits the T315I Mutant and Overcomes Mutation-Based Resistance=== | ||
+ | |||
+ | <!-- | ||
+ | The line below this paragraph, {{ABSTRACT_PUBMED_19878872}}, adds the Publication Abstract to the page | ||
+ | (as it appears on PubMed at http://www.pubmed.gov), where 19878872 is the PubMed ID number. | ||
+ | --> | ||
+ | {{ABSTRACT_PUBMED_19878872}} | ||
==About this Structure== | ==About this Structure== | ||
3IK3 is a 2 chains structure with sequences from [http://en.wikipedia.org/wiki/Mus_musculus Mus musculus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3IK3 OCA]. | 3IK3 is a 2 chains structure with sequences from [http://en.wikipedia.org/wiki/Mus_musculus Mus musculus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3IK3 OCA]. | ||
+ | |||
+ | ==Reference== | ||
+ | <ref group="xtra">PMID:19878872</ref><references group="xtra"/> | ||
[[Category: Mus musculus]] | [[Category: Mus musculus]] | ||
[[Category: Non-specific protein-tyrosine kinase]] | [[Category: Non-specific protein-tyrosine kinase]] | ||
Line 44: | Line 53: | ||
[[Category: Transferase]] | [[Category: Transferase]] | ||
- | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Apr 28 10:53:11 2010'' |
Revision as of 07:53, 28 April 2010
AP24534, a Pan-BCR-ABL Inhibitor for Chronic Myeloid Leukemia, Potently Inhibits the T315I Mutant and Overcomes Mutation-Based Resistance
Template:ABSTRACT PUBMED 19878872
About this Structure
3IK3 is a 2 chains structure with sequences from Mus musculus. Full crystallographic information is available from OCA.
Reference
- O'Hare T, Shakespeare WC, Zhu X, Eide CA, Rivera VM, Wang F, Adrian LT, Zhou T, Huang WS, Xu Q, Metcalf CA 3rd, Tyner JW, Loriaux MM, Corbin AS, Wardwell S, Ning Y, Keats JA, Wang Y, Sundaramoorthi R, Thomas M, Zhou D, Snodgrass J, Commodore L, Sawyer TK, Dalgarno DC, Deininger MW, Druker BJ, Clackson T. AP24534, a pan-BCR-ABL inhibitor for chronic myeloid leukemia, potently inhibits the T315I mutant and overcomes mutation-based resistance. Cancer Cell. 2009 Nov 6;16(5):401-12. PMID:19878872 doi:10.1016/j.ccr.2009.09.028
Page seeded by OCA on Wed Apr 28 10:53:11 2010
Categories: Mus musculus | Non-specific protein-tyrosine kinase | Zhou, T. | Alternative splicing | Atp-binding | Bcr-abl | Cell adhesion | Chromosomal rearrangement | Cml | Cytoplasm | Cytoskeleton | Drug resistance | Inhibitor | Kinase | Lipoprotein | Magnesium | Manganese | Metal-binding | Mutation | Myristate | Nucleotide-binding | Nucleus | Phosphoprotein | Proto-oncogene | Sh2 domain | Sh3 domain | T315i | Transferase